Psychoneuroendocrinology
Volume 32, Issue 5 , Pages 516-531 , June 2007

Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior

  • François Frenois

      Affiliations

    • Integrative Immunology and Behavior Program, University of Illinois at Urbana-Champaign, 212 Edward R. Madigan Laboratory, 1201 West Gregory Drive, Urbana, IL 61801, USA
    • FF and MM contributed equally to the work.
    • ,
  • Maïté Moreau

      Affiliations

    • INRA UMR 1244—CNRS FRE 2723 “Neurobiologie Intégrative”, INSERM Institut François Magendie, 146 rue Léo Saignat, 33077 Bordeaux cedex, France
    • FF and MM contributed equally to the work.
    • ,
  • Jason O’Connor

      Affiliations

    • Integrative Immunology and Behavior Program, University of Illinois at Urbana-Champaign, 212 Edward R. Madigan Laboratory, 1201 West Gregory Drive, Urbana, IL 61801, USA
    • ,
  • Marc Lawson

      Affiliations

    • Integrative Immunology and Behavior Program, University of Illinois at Urbana-Champaign, 212 Edward R. Madigan Laboratory, 1201 West Gregory Drive, Urbana, IL 61801, USA
    • ,
  • Charlotte Micon

      Affiliations

    • INRA UMR 1244—CNRS FRE 2723 “Neurobiologie Intégrative”, INSERM Institut François Magendie, 146 rue Léo Saignat, 33077 Bordeaux cedex, France
    • ,
  • Jacques Lestage

      Affiliations

    • INRA UMR 1244—CNRS FRE 2723 “Neurobiologie Intégrative”, INSERM Institut François Magendie, 146 rue Léo Saignat, 33077 Bordeaux cedex, France
    • ,
  • Keith W. Kelley

      Affiliations

    • Integrative Immunology and Behavior Program, University of Illinois at Urbana-Champaign, 212 Edward R. Madigan Laboratory, 1201 West Gregory Drive, Urbana, IL 61801, USA
    • ,
  • Robert Dantzer

      Affiliations

    • Integrative Immunology and Behavior Program, University of Illinois at Urbana-Champaign, 212 Edward R. Madigan Laboratory, 1201 West Gregory Drive, Urbana, IL 61801, USA
    • Corresponding Author InformationCorresponding author. Tel.: +12177145504; fax: +12172445617.
    • ,
  • Nathalie Castanon

      Affiliations

    • INRA UMR 1244—CNRS FRE 2723 “Neurobiologie Intégrative”, INSERM Institut François Magendie, 146 rue Léo Saignat, 33077 Bordeaux cedex, France

Received 13 October 2006 ,Revised 22 January 2007 ,Accepted 12 March 2007.

References 

  1. Alheid GF. Extended amygdala and basal forebrain. Ann. NY Acad. Sci. 2003;985:185–205
  2. Alheid GF, Heimer L. New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata. Neuroscience. 1988;27:1–39
  3. Alheid GF, Heimer L. Theories of basal forebrain organization and the “emotional motor system”. Prog. Brain Res. 1996;107:461–484
  4. Allan SM, Rothwell NJ. Cytokines and acute neurodegeneration. Nat. Rev. Neurosci. 2001;2:734–744
  5. Anisman H, Merali Z. Cytokines, stress, and depressive illness. Brain Behav. Immun. 2002;16:513–524
  6. Anisman H, Merali Z. Cytokines, stress and depressive illness: brain-immune interactions. Ann. Med. 2003;35:2–11
  7. Anisman H, Kokkinidis L, Merali Z. Further evidence for the depressive effects of cytokines: anhedonia and neurochemical changes. Brain Behav. Immun. 2002;16:544–556
  8. Atkins JB, Chlan-Fourney J, Nye HE, Hiroi N, Carlezon WA, Nestler EJ. Region-specific induction of deltaFosB by repeated administration of typical versus atypical antipsychotic drugs. Synapse. 1999;33:118–128
  9. Avitsur R, Yirmiya R. The immunobiology of sexual behavior: gender differences in the suppression of sexual activity during illness. Pharmacol. Biochem. Behav. 1999;64:787–796
  10. Besedovsky HO, Del Rey A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr. Rev. 1996;17:64–102
  11. Borowski T, Kokkinidis L, Merali Z, Anisman H. Lipopolysaccharide, central in vivo biogenic amine variations, and anhedonia. Neuroreport. 1998;9:3797–3802
  12. Borsody MK, Weiss JM. Alteration of locus coeruleus neuronal activity by interleukin-1 and the involvement of endogenous corticotropin-releasing hormone. Neuroimmunomodulation. 2002;10:101–121
  13. Borsody MK, Weiss JM. The effects of endogenous interleukin-1 bioactivity on locus coeruleus neurons in response to bacterial and viral substances. Brain Res. 2004;1007:39–56
  14. Borsody MK, Weiss JM. The subdiaphragmatic vagus nerves mediate activation of locus coeruleus neurons by peripherally administered microbial substances. Neuroscience. 2005;131:235–245
  15. Bremner JD, Narayan M, Anderson ER, Staib LH, Miller HL, Charney DS. Hippocampal volume reduction in major depression. Am. J. Psychiatry. 2000;157:115–118
  16. Capuron L, Dantzer R. Cytokines and depression: the need for a new paradigm. Brain Behav. Immun. 2003;17(Suppl. 1):S119–S124
  17. Capuron L, Ravaud A, Dantzer R. Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy. J. Clin. Oncol. 2000;18:2143–2151
  18. Capuron L, Ravaud A, Gualde N, Bosmans E, Dantzer R, Maes M, et al. Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy. Psychoneuroendocrinology. 2001;26:797–808
  19. Capuron L, Gumnick JF, Musselman DL, Lawson DH, Reemsnyder A, Nemeroff CB, et al. Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology. 2002;26:643–652
  20. Capuron L, Ravaud A, Neveu PJ, Miller AH, Maes M, Dantzer R. Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol. Psychiatry. 2002;7:468–473
  21. Cardinal RN, Parkinson JA, Hall J, Everitt BJ. Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex. Neurosci. Biobehav. Rev. 2002;26:321–352
  22. Castanon N, Leonard BE, Neveu PJ, Yirmiya R. Effects of antidepressants on cytokine production and actions. Brain Behav. Immun. 2002;16:569–574
  23. Castanon N, Medina C, Mormede C, Dantzer R. Chronic administration of tianeptine balances lipopolysaccharide-induced expression of cytokines in the spleen and hypothalamus of rats. Psychoneuroendocrinology. 2004;29:778–790
  24. Chan RK, Brown ER, Ericsson A, Kovacs KJ, Sawchenko PE. A comparison of two immediate-early genes, c-fos and NGFI-B, as markers for functional activation in stress-related neuroendocrine circuitry. J. Neurosci. 1993;13:5126–5138
  25. Checkley S. The neuroendocrinology of depression and chronic stress. Br. Med. Bull. 1996;52:597–617
  26. Chen J, Kelz MB, Hope BT, Nakabeppu Y, Nestler EJ. Chronic Fos-related antigens: stable variants of deltaFosB induced in brain by chronic treatments. J. Neurosci. 1997;17:4933–4941
  27. Cryan JF, Markou A, Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol. Sci. 2002;23:238–245
  28. Cryan JF, Mombereau C, Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci. Biobehav. Rev. 2005;29:571–625
  29. Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Ann. NY Acad. Sci. 2001;933:222–234
  30. Dantzer R. Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. Eur. J. Pharmacol. 2004;500:399–411
  31. Dantzer R, Wollman E, Vitkovic L, Yirmiya R. Cytokines and depression: fortuitous or causative association?. Mol. Psychiatry. 1999;4:328–332
  32. Deak T, Bellamy C, D’Agostino LG, Rosanoff M, McElderry NK, Bordner KA. Behavioral responses during the forced swim test are not affected by anti-inflammatory agents or acute illness induced by lipopolysaccharide. Behav. Brain Res. 2005;160:125–134
  33. De La Garza R. Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: focus on anhedonia. Neurosci. Biobehav. Rev. 2005;29:761–770
  34. Del Cerro S, Borrell J. Interleukin-1 affects the behavioral despair response in rats by an indirect mechanism which requires endogenous CRF. Brain Res. 1990;528:162–164
  35. Dobrazanski P, Noguchi T, Kovary K, Rizzo CA, Lazo PS, Bravo R. Both products of the fosB gene, FosB and its short form, FosB/SF, are transcriptional activators in fibroblasts. Mol. Cell Biol. 1991;11:5470–5478
  36. Dunn AJ, Swiergiel AH. Effects of interleukin-1 and endotoxin in the forced swim and tail suspension tests in mice. Pharmacol. Biochem. Behav. 2005;81:688–693
  37. Dunn AJ, Wang J, Ando T. Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress. Adv. Exp. Med. Biol. 1999;461:117–127
  38. Dunn AJ, Swiergiel AH, de Beaurepaire R. Cytokines as mediators of depression: what can we learn from animal studies?. Neurosci. Biobehav. Rev. 2005;29:891–909
  39. Elmquist JK, Scammell TE, Jacobson CD, Saper CB. Distribution of Fos-like immunoreactivity in the rat brain following intravenous lipopolysaccharide administration. J. Comp. Neurol. 1996;371:85–103
  40. Frenois F, Le Moine C, Cador M. The motivational component of withdrawal in opiate addiction: role of associative learning and aversive memory in opiate addiction from a behavioral, anatomical and functional perspective. Rev. Neurosci. 2005;16:255–276
  41. Frenois F, Stinus L, Di Blasi F, Cador M, Le Moine C. A specific limbic circuit underlies opiate withdrawal memories. J. Neurosci. 2005;25:1366–1374
  42. Hansen MK, Daniels S, Goehler LE, Gaykema RP, Maier SF, Watkins LR. Subdiaphragmatic vagotomy does not block intraperitoneal lipopolysaccharide-induced fever. Auton. Neurosci. 2000;85:83–87
  43. Hansen MK, Nguyen KT, Goehler LE, Gaykema RP, Fleshner M, Maier SF, et al. Effects of vagotomy on lipopolysaccharide-induced brain interleukin-1beta protein in rats. Auton. Neurosci. 2000;85:119–126
  44. Heimer L, Alheid GF, De Olmos JS, Groenewegen HJ, Haber SN, Harlan RE, et al. The accumbens: beyond the core–shell dichotomy. J. Neuropsychiatry Clin. Neurosci. 1997;9:354–381
  45. Heimer L, Harlan RE, Alheid GF, Garcia MM, De Olmos J. Substantia innominata: a notion which impedes clinical–natomical correlations in neuropsychiatric disorders. Neuroscience. 1997;76:957–1006
  46. Hellstrom IC, Danik M, Luheshi GN, Williams S. Chronic LPS exposure produces changes in intrinsic membrane properties and a sustained IL-beta-dependent increase in GABAergic inhibition in hippocampal CA1 pyramidal neurons. Hippocampus. 2005;15:656–664
  47. Herdegen T, Leah JD. Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res. Rev. 1998;28:370–490
  48. Hirschfeld RM. History and evolution of the monoamine hypothesis of depression. J. Clin. Psychiatry. 2000;61(Suppl. 6):4–6
  49. Jain NK, Kulkarni SK, Singh A. Lipopolysaccharide-mediated immobility in mice: reversal by cyclooxygenase enzyme inhibitors. Methods Find. Exp. Clin. Pharmacol. 2001;23:441–444
  50. Konsman JP, Kelley K, Dantzer R. Temporal and spatial relationships between lipopolysaccharide-induced expression of Fos, interleukin-1beta and inducible nitric oxide synthase in rat brain. Neuroscience. 1999;89:535–548
  51. Konsman JP, Luheshi GN, Bluthe RM, Dantzer R. The vagus nerve mediates behavioural depression, but not fever, in response to peripheral immune signals; a functional anatomical analysis. Eur. J. Neurosci. 2000;12:4434–4446
  52. Konsman JP, Parnet P, Dantzer R. Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci. 2002;25:154–159
  53. Kovacs KJ. C-Fos as a transcription factor: a stressful (re)view from a functional map. Neurochem.Int. 1998;33:287–297
  54. Kovacs KJ, Sawchenko PE. Mediation of osmoregulatory influences on neuroendocrine corticotropin-releasing factor expression by the ventral lamina terminalis. Proc. Nat. Acad. Sci. USA. 1993;90:7681–7685
  55. Kwant A, Sakic B. Behavioral effects of infection with interferon-gamma adenovector. Behav. Brain Res. 2004;151:73–82
  56. Laye S, Parnet P, Goujon E, Dantzer R. Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Brain Res. Mol. Brain Res. 1994;27:157–162
  57. Leonard BE. The immune system, depression and the action of antidepressants. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2001;25:767–780
  58. Lestage J, Verrier D, Palin K, Dantzer R. The enzyme indoleamine 2,3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen. Brain Behav. Immun. 2002;16:596–601
  59. Liotti M, Mayberg HS. The role of functional neuroimaging in the neuropsychology of depression. J. Clin. Exp. Neuropsychol. 2001;23:121–136
  60. Makino M, Kitano Y, Komiyama C, Takasuna K. Human interferon-alpha increases immobility in the forced swimming test in rats. Psychopharmacology (Berl.). 2000;148:106–110
  61. Matthews SC, Paulus MP, Dimsdale JE. Contribution of functional neuroimaging to understanding neuropsychiatric side effects of interferon in hepatitis C. Psychosomatics. 2004;45:281–286
  62. McClung CA, Ulery PG, Perrotti LI, Zachariou V, Berton O, Nestler EJ. DeltaFosB: a molecular switch for long-term adaptation in the brain. Mol. Brain Res. 2004;132:146–154
  63. Merali Z, Brennan K, Brau P, Anisman H. Dissociating anorexia and anhedonia elicited by interleukin-1beta: antidepressant and gender effects on responding for “free chow” and “earned” sucrose intake. Psychopharmacology (Berl.). 2003;165:413–418
  64. Monleon S, D’Aquila P, Parra A, Simon VM, Brain PF, Willner P. Attenuation of sucrose consumption in mice by chronic mild stress and its restoration by imipramine. Psychopharmacology (Berl.). 1995;117:453–457
  65. Morgan JI, Curran T. Immediate-early genes: ten years on. Trends Neurosci. 1995;18:66–67
  66. Mormede C, Palin K, Kelley KW, Castanon N, Dantzer R. Conditioned taste aversion with lipopolysaccharide and peptidoglycan does not activate cytokine gene expression in the spleen and hypothalamus of mice. Brain Behav. Immun. 2004;18:186–200
  67. Nestler EJ, Kelz MB, Chen J. DeltaFosB: a molecular mediator of long-term neural and behavioral plasticity. Brain Res. 1999;835:10–17
  68. Nestler EJ, Barrot M, Self DW. Delta FosB: a sustained molecular switch for addiction. Proc. Nat. Acad. Sci. USA. 2001;98:11042–11046
  69. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron. 2002;34:13–25
  70. Paxinos G, Franklin KBJ. The Mouse Brain in Stereotaxic Coordinates. San Diego: Academic Press; 2001;
  71. Perrotti LI, Hadeishi Y, Ulery PG, Barrot M, Monteggia L, Duman RS, et al. Induction of DeltaFosB in reward-related brain structures after chronic stress. J. Neurosci. 2004;24:10594–10602
  72. Porsolt RD. Animal models of depression: utility for transgenic research. Rev. Neurosci. 2000;11:53–58
  73. Rodriguez JJ, Garcia DR, Nakabeppu Y, Pickel VM. Enhancement of laminar FosB expression in frontal cortex of rats receiving long chronic clozapine administration. Exp. Neurol. 2001;168:392–401
  74. Rosi S, Ramirez-Amaya V, Hauss-Wegrzyniak B, Wenk GL. Chronic brain inflammation leads to a decline in hippocampal NMDA-R1 receptors. J. Neuroinflammation. 2004;1:12
  75. Rosi S, Ramirez-Amaya V, Vazdarjanova A, Worley PF, Barnes CA, Wenk GL. Neuroinflammation alters the hippocampal pattern of behaviorally induced Arc expression. J. Neurosci. 2005;25:723–731
  76. Sammut S, Bethus I, Goodall G, Muscat R. Antidepressant reversal of interferon-alpha-induced anhedonia. Physiol. Behav. 2002;75:765–772
  77. Sheline YI, Sanghavi M, Mintun MA, Gado MH. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J. Neurosci. 1999;19:5034–5043
  78. Shen Y, Connor TJ, Nolan Y, Kelly JP, Leonard BE. Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms in the rat. Life Sci. 1999;65:1773–1786
  79. Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology. 1985;85:367–370
  80. Stone TW. Endogenous neurotoxins from tryptophan. Toxicon. 2001;39:61–73
  81. Suzuki T, Funada M, Sugano Y, Misawa M, Okutomi T, Soma G, et al. Effects of a lipopolysaccharide from Pantoea agglomerans on the cocaine-induced place preference. Life Sci. 1994;54:PL75–PL80
  82. Wichers MC, Maes M. The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression. J. Psychiatry Neurosci. 2004;29:11–17
  83. Wichers MC, Koek GH, Robaeys G, Verkerk R, Scharpe S, Maes M. IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity. Mol. Psychiatry. 2005;10:538–544
  84. Yamano M, Yuki H, Yasuda S, Miyata K. Corticotropin-releasing hormone receptors mediate consensus interferon-alpha YM643-induced depression-like behavior in mice. J. Pharmacol. Exp. Ther. 2000;292:181–187
  85. Yirmiya R. Endotoxin produces a depressive-like episode in rats. Brain Res. 1996;711:163–174
  86. Yirmiya R. Depression in medical illness: the role of the immune system. West. J. Med. 2000;173:333–336

PII: S0306-4530(07)00063-7

doi: 10.1016/j.psyneuen.2007.03.005

Psychoneuroendocrinology
Volume 32, Issue 5 , Pages 516-531 , June 2007

Article Tools

* Image Usage & Resolution